Could JAK inhibitors Increase Survival, Regardless of Molecular Status?

patientpower has 2398 videos Subscribe Here

Description: Could JAK inhibitors increase survival in people with myelofibrosis, even though genetic mutations vary from patient to patient? Dr. Alessandro Vannuchi, an MPN researcher from University of Florence in Italy, discusses study results indicating that treatment with JAK inhibitors may improve survival and quality of life for people with myelofibrosis. Dr. Vannuchi explains how this research shows a positive impact on spleen volume, disease symptoms and survival, regardless of the molecular status of the patient.

Made possible through an educational grant from the Patient Empowerment Network.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 02/05/14
Added : 4 years ago
Category : General